Genenta Science S.p.A. (GNTA) Stock Price & Analysis
Genenta Science S.p.A. (GNTA) closed at USD 0.63 on Friday, October 23, 2026, down 0.02% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0.63; the Oct 23, 2026 session ranged USD 0.63–0.64 on volume of 13,392 shares. Market capitalization is $30.38M, with a 52-week range of USD 0.55–10 (NCM). Source: Nexqual, retrieved October 24, 2026 at 00:27 UTC.
Also available as compact Markdown for AI agents: nexqual.com/GNTA.md
Key facts (GNTA)
- Analysts: None.
- Total return with dividends: 1Y -89.8% vs S&P 500 +14.0%; 5Y -94.3% vs S&P 500 +76.9%.
Analysts (GNTA)
Consensus None.
Total return (dividends reinvested) (GNTA)
| 1Y (from 2025-10-24) | 5Y (from 2021-12-13) | |
|---|---|---|
| Total return | -89.8% | -94.3% |
| S&P 500 (SPY) | +14.0% | +76.9% |
| Per year | -90.0% | -44.5% |
| Volatility (annualized) | 136.6% | 97.1% |
| Max drawdown | -90.7% (Oct 2025→May 2026) | -95.1% (Dec 2021→May 2026) |
GNTA suppliers, customers and competitors (named in its 20-F)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Supplier | AGC Biologics | “have entered into agreements with AGC Biologics to manufacture our LVV and certain drug products for our ongoing clinical programs in” |
Quoted from the company's 20-F filed Apr 1, 2026.
GNTA analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter | — | — | — | $0 | — |
| Next quarter | — | — | — | $0 | — |
| Current fiscal year (ends Dec 2026) | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |
Key Statistics (as of October 24, 2026 at 00:27 UTC)
| Price | USD 0.63 |
|---|---|
| Change | ▼ 0.02% (down) |
| Previous Close | USD 0.63 |
| Open | USD 0.64 |
| Day Range | USD 0.63 – 0.64 |
| 52-Week Range | USD 0.55 – 10 |
| Volume | 13,392 shares |
| Market Cap | $30.38M |
| Exchange | NCM |
Technical Analysis (GNTA)
Nexqual's technical model rates GNTA "SELL" based on 1 bullish and 5 bearish signals across 126 daily candles, as of October 24, 2026 at 00:27 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 35.4 (neutral) |
| vs SMA50 | Below (USD 0.87) |
| MACD | -0.06 (negative) |
Analyst Ratings (GNTA)
Wall Street analysts rate GNTA "None", per Nexqual as of October 24, 2026 at 00:27 UTC.
| Consensus Rating | None |
|---|
Earnings (GNTA)
Source: Nexqual, October 24, 2026 at 00:27 UTC.
Financials & Fundamentals (GNTA)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -38.03% |
| Debt / Equity | 0.35 |
| Current Ratio | 14.16 |
| Total Cash | $28.15M |
| Total Debt | $7.60M |
Source: Nexqual, October 24, 2026 at 00:27 UTC.
Financial Health Score (GNTA)
Nexqual rates Genenta Science S.p.A.'s overall financial health "Weak" across five dimensions, as of October 24, 2026 at 00:27 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Strong — EUR 28M cash vs EUR 8M debt, net cash position |
| Cash Flow | Weak — Operating cash flow -EUR 7M (TTM) |
| Efficiency | Critical — ROE -38%, ROA -17.7% |
Ownership (GNTA)
| Insider Ownership | +43.37% |
|---|---|
| Institutional Ownership | +4.91% |
| Shares Outstanding | 48.22M |
| Float | 18.78M |
| Short % of Float | +0.24% |
Source: Nexqual, October 24, 2026 at 00:27 UTC.
Leadership (GNTA)
Genenta Science S.p.A. is led by Pierluigi Paracchi, Co-Founder, Chairman, CEO & GM, per Nexqual as of October 24, 2026 at 00:27 UTC.
| Co-Founder, Chairman, CEO & GM | Pierluigi Paracchi |
|---|---|
| Chief Financial Officer | Richard B. Slansky |
| Vice President of Corporate Development | Gianfranco De Nigris |
| Finance Director | Barbara Regonini |
Major Backers & Investors (GNTA)
Notable institutional backers of Genenta Science S.p.A. include Eurizon Capital Sgr S.p.a., Smartharvest Portfolios, LLC, Virtu Financial LLC, according to Nexqual as of October 24, 2026 at 00:27 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Eurizon Capital Sgr S.p.a. | 1.53% |
| Smartharvest Portfolios, LLC | 0.19% |
| Virtu Financial LLC | 0.16% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Allianz SE | 0.99% |
Source: Nexqual, October 24, 2026 at 00:27 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| VMI | Valmont Industries, Inc. | USD 435.01 | ▼ 0.2% |
| HON | Honeywell International Inc. | USD 221.15 | ▲ 1.3% |
| MMM | 3M Company | USD 173.46 | ▼ 1.2% |
| CNI | Canadian National Railway Compa | USD 123.15 | ▼ 1.42% |
| VRT | Vertiv Holdings, LLC | USD 194.32 | ▼ 0.65% |
| NOC | Northrop Grumman Corporation | USD 551.44 | ▼ 0.16% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 24, 2026 at 00:27 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt